Novo Nordisk A/SNYSE:NVO
- LAST PRICE139.0800
- TODAY'S CHANGE (%)-3.9000 (-2.7277%)
- Bid / Lots139.0700/ 1
- Ask / Lots139.0800/ 1
- Open / Previous Close141.3400 / 142.9800
- Day Range
- 52 Week Range
- Volume6,994,071
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVO |
|---|---|---|
| 09:32 ET | 22885 | 140.895 |
| 09:34 ET | 51523 | 141.135 |
| 09:36 ET | 32191 | 141.17 |
| 09:38 ET | 28802 | 141.12 |
| 09:39 ET | 28261 | 141.08 |
| 09:41 ET | 41535 | 141.18 |
| 09:43 ET | 18369 | 141.25 |
| 09:45 ET | 12451 | 141.14 |
| 09:48 ET | 17930 | 141.085 |
| 09:50 ET | 26111 | 141.07 |
| 09:52 ET | 8978 | 141.1 |
| 09:54 ET | 13182 | 141.07 |
| 09:56 ET | 23161 | 141.159 |
| 09:57 ET | 17456 | 141.0605 |
| 09:59 ET | 20479 | 141.0101 |
| 10:01 ET | 20364 | 141.22 |
| 10:03 ET | 22073 | 141.09 |
| 10:06 ET | 15116 | 141.045 |
| 10:08 ET | 9947 | 141.1352 |
| 10:10 ET | 18572 | 140.92 |
| 10:12 ET | 17258 | 140.97 |
| 10:14 ET | 9956 | 141.1 |
| 10:15 ET | 19763 | 141.07 |
| 10:17 ET | 20703 | 140.96 |
| 10:19 ET | 19309 | 141.02 |
| 10:21 ET | 24919 | 141.08 |
| 10:24 ET | 15553 | 141.175 |
| 10:26 ET | 14688 | 141.43 |
| 10:28 ET | 19231 | 141.16 |
| 10:30 ET | 7594 | 141.17 |
| 10:32 ET | 15729 | 141.28 |
| 10:33 ET | 7415 | 141.255 |
| 10:35 ET | 5570 | 141.385 |
| 10:37 ET | 8179 | 141.42 |
| 10:39 ET | 10139 | 141.37 |
| 10:42 ET | 8974 | 141.4 |
| 10:44 ET | 13332 | 141.25 |
| 10:46 ET | 17498 | 141.11 |
| 10:48 ET | 24984 | 141.11 |
| 10:50 ET | 6975 | 141.07 |
| 10:51 ET | 39693 | 140.93 |
| 10:53 ET | 7283 | 141.07 |
| 10:55 ET | 13138 | 140.85 |
| 10:57 ET | 26213 | 140.62 |
| 11:00 ET | 159170 | 140.33 |
| 11:02 ET | 463613 | 137.94 |
| 11:04 ET | 218167 | 138.64 |
| 11:06 ET | 94915 | 138.35 |
| 11:08 ET | 108278 | 138.2 |
| 11:09 ET | 230364 | 138.1 |
| 11:11 ET | 107673 | 138.26 |
| 11:13 ET | 86264 | 138.47 |
| 11:15 ET | 172215 | 138.16 |
| 11:18 ET | 85151 | 138.305 |
| 11:20 ET | 58430 | 138.55 |
| 11:22 ET | 60559 | 138.53 |
| 11:24 ET | 45009 | 138.45 |
| 11:26 ET | 54558 | 138.105 |
| 11:27 ET | 98102 | 137.95 |
| 11:29 ET | 93868 | 137.54 |
| 11:31 ET | 257939 | 136.92 |
| 11:33 ET | 97082 | 137.55 |
| 11:36 ET | 94392 | 137.23 |
| 11:38 ET | 59677 | 137.22 |
| 11:40 ET | 49104 | 137.385 |
| 11:42 ET | 35752 | 137.48 |
| 11:44 ET | 30945 | 137.625 |
| 11:45 ET | 45979 | 137.64 |
| 11:47 ET | 69007 | 137.69 |
| 11:49 ET | 51584 | 137.817 |
| 11:51 ET | 36675 | 137.79 |
| 11:54 ET | 37369 | 137.84 |
| 11:56 ET | 44853 | 137.89 |
| 11:58 ET | 38706 | 137.905 |
| 12:00 ET | 28750 | 138.06 |
| 12:02 ET | 38151 | 137.705 |
| 12:03 ET | 27070 | 137.67 |
| 12:05 ET | 31598 | 137.81 |
| 12:07 ET | 25255 | 137.84 |
| 12:09 ET | 27159 | 137.76 |
| 12:12 ET | 30988 | 137.87 |
| 12:14 ET | 50921 | 137.57 |
| 12:16 ET | 26650 | 137.5735 |
| 12:18 ET | 42689 | 137.075 |
| 12:20 ET | 79022 | 136.945 |
| 12:21 ET | 53963 | 136.98 |
| 12:23 ET | 31910 | 136.962 |
| 12:25 ET | 61040 | 137.1 |
| 12:27 ET | 42940 | 137.25 |
| 12:30 ET | 36847 | 137.36 |
| 12:32 ET | 36168 | 137.3125 |
| 12:34 ET | 32745 | 137.21 |
| 12:36 ET | 28192 | 137.4 |
| 12:38 ET | 68814 | 137.34 |
| 12:39 ET | 28303 | 137.43 |
| 12:41 ET | 32093 | 137.86 |
| 12:43 ET | 33361 | 138 |
| 12:45 ET | 49795 | 138.24 |
| 12:48 ET | 44543 | 138.56 |
| 12:50 ET | 59705 | 138.66 |
| 12:52 ET | 73378 | 138.74 |
| 12:54 ET | 37265 | 138.8099 |
| 12:56 ET | 136114 | 138.69 |
| 12:57 ET | 117963 | 139.13 |
| 12:59 ET | 238793 | 138.87 |
Today
Yesterday
DJ Big Pharma Stocks Sell Off as Biden Calls for Lower Drug Prices -- Barrons.com, from 23 hours ago by Dow Jones
23 hours ago by Dow JonesDJ Conagra Took a GLP-1 Hit. Why it is Stock Is Worth a Look. -- Barrons.com, from 12:22PM ET on Tuesday Jul 02, 2024 by Dow Jones
12:22PM ET on Tuesday Jul 02, 2024 by Dow JonesDJ Big Pharma Stocks Sell Off as Biden Calls for Lower Drug Prices -- Barrons.com, from 10:49AM ET on Tuesday Jul 02, 2024 by Dow Jones
10:49AM ET on Tuesday Jul 02, 2024 by Dow JonesDJ Novo Nordisk Likely to Raise Sales Target, Set EBIT at Lower End of Range -- Market Talk, from 7:20AM ET on Tuesday Jul 02, 2024 by Dow Jones
7:20AM ET on Tuesday Jul 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novo Nordisk A/S | 485.0B | 48.5x | +18.50% |
Catalent Inc | 10.2B | -8.7x | --- |
Perrigo Company PLC | 3.5B | 8,294.3x | --- |
Royalty Pharma PLC | 15.5B | 14.6x | +1.83% |
Jazz Pharmaceuticals PLC | 6.6B | 21.4x | -3.53% |
Organon & Co | 5.2B | 5.0x | -14.04% |
Company Information
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Contact Information
- Headquarters
- Novo Alle 1BAGSVAERD, Denmark 2880
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Helge Lund
- President, Chief Executive Officer
- Lars Fruergaard Joergensen
- Vice Chairman of the Board
- Henrik Poulsen
- Chief Financial Officer, Executive Vice President
- Karsten Munk Knudsen
- Executive Vice President - International Operations
- Maziar Doustdar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $485.0B |
|---|---|
Revenue (TTM) | $35.2B |
Shares Outstanding | 3.4B |
Dividend Yield | 1.34% |
Annual Dividend Rate | 1.8587 USD |
Ex-Dividend Date | 03-22-24 |
Pay Date | 04-02-24 |
Beta | 0.41 |
EPS | $2.87 |
Book Value | $3.44 |
P/E Ratio | 48.5x |
Price/Sales (TTM) | 13.8 |
Price/Cash Flow (TTM) | 34.4x |
Operating Margin | 44.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
